Ripretinib

ATC L01EX19 · 10 markets · 13 records

Ripretinib 10 markets · 13 records Forms

AU 3 records · 2 strengths

  • 50 mgtabletQINLOCKQINLOCK ripretinib 50 mg tablet bottle also in US·GB·CA +3 unknown

Records without a stated strength · 1 QINLOCK

CN 2 records · 1 strengths

US 1 records · 1 strengths

GB 1 records · 1 strengths

CA 1 records · 1 strengths

SG 1 records · 1 strengths

ES 1 records · 1 strengths

TW 1 records · 1 strengths

HK 1 records · 1 strengths

    Records without a stated strength · 1 QINLOCK

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 QINLOCK

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.